Eiken Chemical Co Ltd
TSE:4549
EV/EBIT
Enterprise Value to EBIT
Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.
Market Cap | EV/EBIT | ||||
---|---|---|---|---|---|
JP |
Eiken Chemical Co Ltd
TSE:4549
|
74.2B JPY | 18.3 | ||
CH |
Alcon AG
SIX:ALC
|
39.6B CHF | 37.9 | ||
JP |
Hoya Corp
TSE:7741
|
6.6T JPY | 29.6 | ||
DK |
Coloplast A/S
CSE:COLO B
|
191.1B DKK | 29.9 | ||
US |
Align Technology Inc
NASDAQ:ALGN
|
20.1B USD | 29 | ||
US |
Cooper Companies Inc
NYSE:COO
|
19.3B USD | 40.9 | ||
CN |
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
58.9B CNY | 30.1 | ||
UK |
ConvaTec Group PLC
LSE:CTEC
|
5.2B GBP | 50.9 | ||
US |
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
5.8B USD | 26 | ||
US |
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.7B USD | 11.8 | ||
CA |
B
|
Bausch + Lomb Corp
NYSE:BLCO
|
5.1B USD | 42.1 |
EV/EBIT Forward Multiples
Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.